BioAtla, Inc. Common Stock(BCAB)

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership.

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

Snapshot
$3.87
52-Week Range
$3.12 – $71.50
YTD
-85.51%
IV Rank (30D)
81.19
Straddle Price
$5.15
P/C Vol Ratio
0.00
Market Cap
$0.0B
Fair Value
+50.0% vs price
Confidence: 5% Alpha Score: 2.37

A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.

  • DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
  • Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
  • DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 0.5% and dividend payments are stable.
  • P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
  • Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
  • Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
  • Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
  • Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
10-yr Treasury (rf)4.53%
Beta vs SPY1.00
Cost of Equity (CAPM)10.03% (VRP-adj)
WACC10.01%
Volatility Risk Premium+1329.3pp (IV − HV30), ERP adj +50bps
Effective Tax Rate21.0%
Rev. Growth (YoY, DCF input)+3.0%
DCF Horizon10 years explicit + fade
Forward Tilt (NTM/TTM)×1.03 (applied to P/E, EV/EBITDA, P/S)
Free Cash Flow (TTM)$-0.0B
Return on Equity (TTM)135.7%
Book / Price-834.5%
Gross Margin (TTM)100.0%
FCF Margin (TTM)-1859.2%
Quality Score2/6 — normal (10y DCF)
SMA 50$4.37 (Market Anchor value)
SMA 20 / Bollinger Mid$3.71
Bollinger Width / SMA20835.3% (drives anchor stability)
Net Debt$-0.0B
Market Cap$0B
Peers used for multiples: AMGN, BIIB, EXEL, GILD, KRYS, MRNA, NBIX, RVMD
Blended Fair Value
$8.55
Current Price
$3.86
Deviation
+50.0%
MethodImplied PriceWeightDetail
DCF n/a 0%
DDM (Gordon) n/a 0%
Peer P/E n/a 0% median 22.1× · 6 peers
Peer EV/EBITDA n/a 0% median 13.9× · 6 peers
Peer P/B n/a 0% median 6.6× · 8 peers
Peer P/S $8.55 100% median 5.2× · 7 peers
Market Anchor (SMA50) $4.37 0% stability 0% (BB-width)
Options Expected (B-L 30d) n/a 0%
As of 2026-06-12 · updated 2026-06-12 20:59:55.687000
Info
Industry (SIC)
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) (2836)
Exchange
XNAS
Market Cap
$0.0B

BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs. The company's operations are organized on a single reportable segment, which includes all activities related to the discovery, development, and commercialization of its CAB pr…

Price History
Seasonality
MonthAvg ReturnYears of Data
Jan -29.79% 6
Feb -4.15% 6
Mar -4.23% 6
Apr -6.16% 6
May -17.81% 6
Jun -1.06% 6
Jul +8.41% 5
Aug +33.55% 5
Sep -4.96% 5
Oct -4.65% 5
Nov +17.61% 5
Dec -17.11% 6
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators
SMA 20: $3.69
SMA 50: $4.31
SMA 200: $20.91
Current: $3.86
EMA 12: $3.64
EMA 26: $3.93
MACD: -0.2937 | Signal: 0.0836
BEARISH
ADX (14): 18.48
RANGE
+DI: 23.83
−DI: 21.68
Momentum Oscillators
RSI (14): 47.97
NEUTRAL
Stoch %K: 55.34
Stoch %D: 43.58
Williams %R: -28.16
Volume & Volatility
BB Upper: $4.18
BB Lower: $3.19
NEUTRAL
OBV: -1,629,318
Vol SMA 20: 54,890
Vol ROC: 129.56%
ATR: $0.43
True Range: $0.49
HV 20: 84.2%
HV 30: 87.1%
HV 60: 116.2%

Data Summary
Data Points: 500
Last Updated: 2026-06-12T21:15:10.959000
Date Range: 2024-06-14T00:00:00 – 2026-06-12T00:00:00
AI Analysis

Choose Frenzy-Fast™ for quick analysis or Frenzy-Pro™ for comprehensive analysis.

Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.

News
Earnings History
6 of 6 under expected move
Each row pairs the pre-earnings straddle-implied expected move with the realized close-to-close move. Sorted oldest first.
Earnings Date Timing Expected Move Actual Move Ratio Outcome
2024-08-08 After-Close 86.04% 0.00% 0.00x Within
2024-11-07 After-Close 32.56% 1.40% 0.04x Within
2025-03-27 Pre-Market 73.39% 14.60% 0.20x Within
2025-08-07 Pre-Market 1222.57% 4.84% 0.00x Within
2025-11-13 After-Close 640.44% 20.66% 0.03x Within
2026-03-02 After-Close 1611.57% 1.96% 0.00x Within
Options Activity
IV Rank (30D)
81.19
IV Rank (7D)
81.19
Avg IV
1492.2%
Straddle (30D)
$5.15
Straddle (7D)
$5.15
P/C Volume
0.00
Spread Scanner GPU

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score (GPU scanner)

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.

Stage 2 — Skew Adjustment (±25% cap)

RR25 and BF25 from the live options chain. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Enter a ticker to scan for optimal spread opportunities.

Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.

Volatility Surface

Enter a ticker to render the implied volatility surface.

IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis
Beta (1Y vs SPY)
0.22
Correlation (SPY)
2.1%
0.00
Ann. Volatility
133.5%
SPY Volatility
12.3%

Low volatility - stock moves less than market

Beta & Alpha Over Time
Institutional Ownership (13F)
Latest filings — 2026-03-31
Diluted shares outstanding: 1,255,800 (as of 2026-03-31)

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

38 filers15,800,735 shares$3.21M value1258.22% of float
# Filer Shares Value % of Total % of Float Period
1 VANGUARD GROUP INC Custodian 1,945,795 $1.11M 34.40% 154.94% 2025-12-31
2 ACORN CAPITAL ADVISORS, LLC 5,406,345 $865.01K 26.92% 430.51% 2026-03-31
3 MILLENNIUM MANAGEMENT LLC Custodian 2,756,674 $443.82K 13.81% 219.52% 2026-03-31
4 GEODE CAPITAL MANAGEMENT, LLC Custodian 689,182 $110.98K 3.45% 54.88% 2026-03-31
5 DEUTSCHE BANK AG\ Custodian 525,352 $84.06K 2.62% 41.83% 2026-03-31
6 RENAISSANCE TECHNOLOGIES LLC 510,514 $82.19K 2.56% 40.65% 2026-03-31
7 BlackRock, Inc. Custodian 480,931 $77.43K 2.41% 38.30% 2026-03-31
8 CITADEL ADVISORS LLC Custodian 435,675 $70.14K 2.18% 34.69% 2026-03-31
9 UBS Group AG Custodian 375,569 $60.47K 1.88% 29.91% 2026-03-31
10 Sheets Smith Investment Management 67,000 $46.09K 1.43% 5.34% 2025-09-30
11 MARSHALL WACE, LLP Custodian 277,630 $44.42K 1.38% 22.11% 2026-03-31
12 PVG ASSET MANAGEMENT CORP 69,000 $39.17K 1.22% 5.49% 2025-12-31
13 ADAR1 Capital Management, LLC 228,107 $36.73K 1.14% 18.16% 2026-03-31
14 MORGAN STANLEY Custodian 43,653 $24.78K 0.77% 3.48% 2025-12-31
15 STATE STREET CORP 151,377 $24.37K 0.76% 12.05% 2026-03-31
16 NORTHERN TRUST CORP Custodian 103,494 $16.66K 0.52% 8.24% 2026-03-31
17 SIMPLEX TRADING, LLC Custodian 73,901 $11.90K 0.37% 5.88% 2026-03-31
18 Stonepine Capital Management, LLC 65,387 $10.53K 0.33% 5.21% 2026-03-31
19 XTX Topco Ltd 56,614 $9.12K 0.28% 4.51% 2026-03-31
20 MAI Capital Management Custodian 51,504 $8.29K 0.26% 4.10% 2026-03-31
21 Kestra Advisory Services, LLC 44,250 $7.12K 0.22% 3.52% 2026-03-31
22 SUSQUEHANNA INTERNATIONAL GROUP, LLP Custodian 39,056 $6.29K 0.20% 3.11% 2026-03-31
23 StoneX Group Inc. 29,466 $4.74K 0.15% 2.35% 2026-03-31
24 COMMONWEALTH EQUITY SERVICES, LLC 25,300 $4.07K 0.13% 2.01% 2026-03-31
25 JANE STREET GROUP, LLC Custodian 23,142 $3.73K 0.12% 1.84% 2026-03-31
3 filers$17.55K notional
# Filer Notional Value % of Total Period
1 JANE STREET GROUP, LLC Custodian $11.30K 64.41% 2026-03-31
2 CITADEL ADVISORS LLC Custodian $6.10K 34.77% 2026-03-31
3 SIMPLEX TRADING, LLC Custodian $144 0.82% 2026-03-31
1 filers$32 notional
# Filer Notional Value % of Total Period
1 SIMPLEX TRADING, LLC Custodian $32 100.00% 2026-03-31
Insider Activity
Latest: 2026-06-05
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
Filed Reporter Role Action Shares Avg Price Net $ Link
2026-06-05 Eric Sievers Chief Medical Officer Tax (F) −494 $1.19 -$587 EDGAR
2026-06-05 Christian Vasquez Chief Financial Officer Tax (F) −257 $1.37 -$352 EDGAR
2026-06-05 JAY M PHD SHORT Chief Executive Officer Tax (F) −898 $1.25 -$1.1K EDGAR
2026-03-12 Christian Vasquez Chief Financial Officer Award (A) +240,000 EDGAR
2026-03-12 Eric Sievers Chief Medical Officer Award (A) +240,000 EDGAR
2026-03-12 JAY M PHD SHORT Chief Executive Officer Award (A) +430,000 EDGAR
2026-03-02 Eric Sievers Chief Medical Officer Tax (F) −3,140 $0.25 -$776 EDGAR
2026-03-02 Christian Vasquez Chief Financial Officer Tax (F) −1,802 $0.25 -$445 EDGAR
2026-03-02 RICHARD A WALDRON Former Chief Financial Officer Tax (F) −2,729 $0.25 -$674 EDGAR
2026-03-02 JAY M PHD SHORT Chief Executive Officer Tax (F) −7,728 $0.25 -$1.9K EDGAR
2025-12-01 RICHARD A WALDRON Chief Financial Officer Tax (F) −2,371 $0.90 -$2.1K EDGAR
2025-12-01 Christian Vasquez See Remarks Tax (F) −1,566 $0.90 -$1.4K EDGAR
2025-12-01 JAY M PHD SHORT Chief Executive Officer Tax (F) −6,347 $0.90 -$5.7K EDGAR
2025-12-01 Eric Sievers Chief Medical Officer Tax (F) −2,729 $0.90 -$2.5K EDGAR
2025-09-02 Christian Vasquez See Remarks Tax (F) −1,566 $0.46 -$713 EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
Insider Holdings
12 insiders · @ $3.86
Officers, directors, and 10%+ owners ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
# Insider Role Shares Disclosed Exposure Lifetime OM Net Filings Last Filed
1 RICHARD A WALDRON Former Chief Financial Officer 343,421 $1.33M -$779.9K 36 2026-03-02
2 Scott Andrew Smith Director 321,550 $1.24M -$1.57M 44 2025-06-18
3 Guy Levy Director 232,229 $896.4K -$12.34M 5 2021-09-30
4 LAWRENCE STEINMAN Director 78,459 $302.9K -$24.5K 10 2025-06-18
5 MARY ANN GRAY Director 77,397 $298.8K $0 9 2025-06-18
6 Eddie Williams Director 60,200 $232.4K $0 9 2025-06-18
7 SYLVIA MCBRINN Director 59,125 $228.2K $97.1K 13 2025-06-18
8 JAY M PHD SHORT Chief Executive Officer 58,340 $225.2K -$11.28M 45 2026-06-05
9 Susan Moran Director 52,307 $201.9K $0 5 2025-06-18
10 Eric Sievers Chief Medical Officer 11,840 $45.7K -$329.1K 50 2026-06-05
11 Christian Vasquez Chief Financial Officer 10,347 $39.9K $88.2K 41 2026-06-05
12 Himalaya Parent LLC 10%+ Owner 50 $193 $0 2 2022-06-03
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
ETF Holders
# ETF Provider Weight $ Exposure ETF AUM As Of
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.

P/B Ratio-0.2
P/S Ratio3.0
EV/EBITDA-0.1
TTM Revenue$0.0B
TTM Net Income$-0.1B
TTM EPS$-41.72
ROE135.7%